GlassScriptPhysician profile
Michelle Lee
NPI 1922603125
$1,449.05
in general payments reported to CMS, 2019-2025
21 companies · $344 in 2025
The $344 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $212 · 2022: $506 · 2023: $45.30 · 2024: $341 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $717 · Education: $13.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $716.65 |
| Education | $13.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $318.39 | 2021-2022 | |
| Abbvie INC. | $209.26 | 2021-2025 | |
| Insulet Corporation | $132.76 | 2024-2025 | Omnipod |
| Bayer Healthcare Pharmaceuticals INC. | $117.04 | 2022 | |
| Radius Health, INC. | $113.79 | 2024-2025 | Tymlos |
| Amgen INC. | $101.99 | 2023-2025 | Tepezza, Evenity, Prolia |
| Tandem Diabetes Care, INC. | $57.55 | 2024-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Dexcom, INC. | $54.73 | 2023-2025 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $45.01 | 2024-2025 | |
| Medtronic, INC. | $42.79 | 2024 | Minimed 780g |
| Beta Bionics, INC. | $37.24 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Cequr Corporation | $33.63 | 2024 | Cequr Simplicity |
| Mannkind Corporation | $30.35 | 2025 | |
| Hologic Sales and Service, LLC | $23.98 | 2021 | |
| Corcept Therapeutics | $23.80 | 2024 | Korlym |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $21.53 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.87 | 2022 | |
| Lundbeck LLC | $19.65 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.53 | 2022 | |
| Horizon Therapeutics Plc | $13.08 | 2023 | Tepezza |
| Amneal Pharmaceuticals LLC | $13.08 | 2024 | Unithroid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.